Alex Zhavoronkov, Founder and CEO of Insilico Medicine, discusses the implications after an AI-discovered lung drug developed by his company showed promise in reversing biological signs of aging. (Source: Bloomberg)
Source: Bloomberg Markets — This article was automatically imported from the source. Read full article at original source →
